Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Mickaël, Bourgeois"'
Autor:
Alexandre Lugat, Clément Bailly, Michel Chérel, Caroline Rousseau, Françoise Kraeber-Bodéré, Caroline Bodet-Milin, Mickaël Bourgeois
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Radioimmunoconjugates have been used for over 30 years in nuclear medicine applications. In the last few years, advances in cancer biology knowledge have led to the identification of new molecular targets specific to certain patient subgroups. The us
Externí odkaz:
https://doaj.org/article/c494c40b0e3b4e859e00d8d1410fc8c2
Publikováno v:
Pharmaceutics, Vol 15, Iss 6, p 1733 (2023)
Targeted radionuclide therapy has become increasingly prominent as a nuclear medicine subspecialty. For many decades, treatment with radionuclides has been mainly restricted to the use of iodine-131 in thyroid disorders. Currently, radiopharmaceutica
Externí odkaz:
https://doaj.org/article/af598a2264324114b411e2b9cf041f61
Autor:
Elodie A. Pérès, Jérôme Toutain, Louis-Paul Paty, Didier Divoux, Méziane Ibazizène, Stéphane Guillouet, Louisa Barré, Aurélien Vidal, Michel Cherel, Mickaël Bourgeois, Myriam Bernaudin, Samuel Valable
Publikováno v:
EJNMMI Research, Vol 9, Iss 1, Pp 1-15 (2019)
Abstract Background Diacetyl-bis(N4-methylthiosemicarbazone), labeled with 64Cu (64Cu-ATSM) has been suggested as a promising tracer for imaging hypoxia. However, various controversial studies highlighted potential pitfalls that may disable its use a
Externí odkaz:
https://doaj.org/article/e90ccfff5e35401c9889fec7302f79d4
Autor:
Elise Vène, Kathleen Jarnouen, Catherine Ribault, Manuel Vlach, Yann Verres, Mickaël Bourgeois, Nicolas Lepareur, Sandrine Cammas-Marion, Pascal Loyer
Publikováno v:
Pharmaceutics, Vol 14, Iss 4, p 804 (2022)
In order to identify the peptides, selected from the literature, that exhibit the strongest tropism towards human hepatoma cells, cell uptake assays were performed using biotinylated synthetic peptides bound to fluorescent streptavidin or engrafted o
Externí odkaz:
https://doaj.org/article/a6bd928abdf74b0d8bb87eceb2b43b2a
Autor:
Floriane Etienne, Maxime Berthaud, Frédérique Nguyen, Karine Bernardeau, Catherine Maurel, Caroline Bodet-Milin, Maya Diab, Jérôme Abadie, Valérie Gouilleux-Gruart, Aurélien Vidal, Mickaël Bourgeois, Nicolas Chouin, Catherine Ibisch, François Davodeau
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Antibodies directed against CD22 have been used in radioimmunotherapy (RIT) clinical trials to treat patients with diffuse large B-cell lymphoma (DLBCL) with promising results. However, relevant preclinical models are needed to facilitate the evaluat
Externí odkaz:
https://doaj.org/article/7e71b67d23e4426780eb2e53d47f0a08
Autor:
Clément Bailly, Aurelien Vidal, Coralie Bonnemaire, Françoise Kraeber-Bodéré, Michel Chérel, Amandine Pallardy, Caroline Rousseau, Emmanuel Garcion, Franck Lacoeuille, François Hindré, Samuel Valable, Myriam Bernaudin, Caroline Bodet-Milin, Mickaël Bourgeois
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Glioblastoma is the most common malignant adult brain tumor and has a very poor patient prognosis. The mean survival for highly proliferative glioblastoma is only 10 to 14 months despite an aggressive current therapeutic approach known as Stupp’s p
Externí odkaz:
https://doaj.org/article/5d57d52a477a4b4cbe32871d5e62f89f
Autor:
Alexandre Lugat, Éric Frampas, Yann Touchefeu, Éric Mirallié, Maëlle Le Bras, Hélène Senellart, Aurore Rauscher, Vincent Fleury, Loïc Campion, Vincent Rohmer, Olivier-François Couturier, Rachida Lebtahi, François Rouzet, Philippe Ruszniewski, Françoise Kraeber-Bodéré, Mickaël Bourgeois, Catherine Ansquer
Publikováno v:
Cancers; Volume 15; Issue 2; Pages: 513
The aim of this multicentric study was to prospectively compare 68Ga-DOTANOC PET/CT versus somatostatin receptor scintigraphy (SRS) with SPECT/CT, combined with multiphasic CT scan and MRI in patients with grade 1 or 2 gastroenteropancreatic neuroend
Autor:
Hanadi Nahas, Clarisse Brossard, Elise Vène, Stébastien Gouard, Michel Chérel, Mickaël Bourgeois, Pascal Loyer, Nicolas Lepareur, Sandrine Cammas-Marion
Publikováno v:
15th Workshop New modalities in Cancer Imaging and Therapy
15th Workshop New modalities in Cancer Imaging and Therapy, Oct 2022, Erquy, France. pp.S41-S41
15th Workshop New modalities in Cancer Imaging and Therapy, Oct 2022, Erquy, France. pp.S41-S41
International audience; Meeting Abstract P-19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c021b279f9a02b6622e22185acddd019
https://hal.science/hal-04011144
https://hal.science/hal-04011144
Autor:
Clément Bailly, Sébastien Gouard, François Guérard, Benjamin Chalopin, Thomas Carlier, Alain Faivre-Chauvet, Patricia Remaud-Le Saëc, Mickaël Bourgeois, Nicolas Chouin, Latifa Rbah-Vidal, Raphaël Tripier, Ferid Haddad, Françoise Kraeber-Bodéré, Caroline Bodet-Milin, Michel Chérel
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 10, p 2564 (2019)
Although positron emission tomography (PET) imaging with 18-Fluorodeoxyglucose (18F-FDG) is a promising technique in multiple myeloma (MM), the development of other radiopharmaceuticals seems relevant. CD138 is currently used as a standard marker for
Externí odkaz:
https://doaj.org/article/122cd9e6f42646f0947532ad87f73e51
Autor:
Clarisse Brossard, Mickaël Bourgeois, Stébastien Gouard, Christelle Bouvry, Elise Vène, Hanadi Nahas, Michel Chérel, Pascal Loyer, Sandrine Cammas-Marion, Nicolas Lepareur
Publikováno v:
International Symposium on Radiopharmaceutical Sciences iSRS 2022
International Symposium on Radiopharmaceutical Sciences iSRS 2022, May 2022, Nantes, France. 108, pp.S153-S153, 2022, ⟨10.1016/s0969-8051(22)00327-4⟩
International Symposium on Radiopharmaceutical Sciences iSRS 2022, May 2022, Nantes, France. 108, pp.S153-S153, 2022, ⟨10.1016/s0969-8051(22)00327-4⟩
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba6e233a533c16708f0073928f448403
https://hal.science/hal-03715034
https://hal.science/hal-03715034